References
1
Bonjouklian R.
Smitka TA.
Doolin LE.
Molloy RM.
Debono M.
Shaffer SA.
Moore RE.
Stewart JB.
Patterson GML.
Tetrahedron
1991,
47:
7739
2a
Nettleton DE.
Doyle TW.
Krishnan B.
Matsumoto GK.
Clardy J.
Tetrahedron Lett.
1985,
26:
4011
2b
Bush JA.
Long BH.
Catino JJ.
Bradner WT.
Tomita K.
J. Antibiot.
1987,
40:
668
3a
Tamaoki T.
Nomoto H.
Takahishi I.
Kato Y.
Morimoto M.
Tomita F.
Biochem. Biophys. Res. Commun.
1986,
135:
397
3b
Funato N.
Takayanagi H.
Konda Y.
Toda Y.
Harigaya Y.
Iwai Y.
Omura S.
Tetrahedron Lett.
1994,
35:
1251
3c
Oka S.
Kodama M.
Takada H.
Tomizuka N.
Suzuki H.
Agric G.
Biol. Chem.
1986,
50:
2723
4
Moody CJ.
Rahimtoola KF.
J. Org. Chem.
1992,
57:
2105
5a Omura S, Iwai Y, and Hirano A. inventors; Japan Kokai 7,873,501.
; Chem. Abstr. 1978, 89, 178086b
5b Omura S, Iwai Y, and Hirano A. inventors; Ger. Offen., 2,745,326.
; Chem. Abstr. 1978, 89, 58348y
6
Omura S.
Iwai Y.
Hirano A.
Nakagawa A.
Awaya J.
Tsuchiya H.
Takahashi Y.
Masuma R.
J. Antibiot.
1977,
30:
275
7a
Link JT.
Danishefsky SJ.
Tetrahedron Lett.
1994,
35:
9135
7b
Wood JL.
Petsch DT.
Stoltz BM.
Hawkins EM.
Elbaum D.
Stover DR.
Synthesis
1999,
1529
8
Gribble GW.
Berthel SJ.
Stud. Nat. Prod. Chem.
1993,
12:
365
9
Akinaga S.
Sugiyama K.
Akiyama T.
Anti-Cancer Drug Des.
2000,
15:
43
10
Brunton RJ.
Drayson FK.
Plant SGP.
Tomlinson ML.
J. Chem. Soc.
1956,
4783
11a
Bhide GV.
Tikotkar NL.
Tilak BD.
Chem. Ind. (London)
1957,
363
11b
Mann FG.
Willcox TJ.
J. Chem. Soc.
1958,
1525
11c
Royer H.
Joseph D.
Prim D.
Kirsch G.
Synth. Commun.
1998,
28:
1239
12
Pindur U.
Kim Y.-S.
J. Heterocycl. Chem.
1996,
33:
623
13a
Beccalli EM.
Marchesini A.
Pilati T.
Tetrahedron
1993,
49:
4741
13b
Beccalli EM.
Gelmi ML.
Marchesini A.
Tetrahedron
1998,
54:
6909
14
Merlic CA.
McInnes DM.
Tetrahedron Lett.
1997,
38:
7661
15
Somei M.
Kodama A.
Heterocycles
1992,
34:
1285
16a
Spectral Data for 1-Oxo-6-chloro-1,2,3,4-tetrahydrocarbazole (
4e): mp 218 °C (lit.
[22]
mp 220 °C). IR (KBr): 3269.91, 3065.63, 2944.19, 2867.84, 1652.68, 1539.99, 1481.58, 810.98, 734.34 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.27-2.32 (m, 2 H, CH2), 2.67 (t, J = 6.0 Hz, 2 H, CH2), 2.98 (t, J = 5.6 Hz, 2 H, CH2), 7.32-7.38 (m, 2 H, ArH), 7.65 (s, 1 H, ArH), 8.97 (s, 1 H, NH). MS (EI):
m/z = 221 [M + 2], 219 [M+]. Anal. Calcd for C12H10ClNO: C, 65.61; H, 4.59; N, 6.38. Found: C, 65.49; H, 4.51; N, 6.25.
16b
Spectral Data for 3,8-Dichloroindolo[2,3-
a
]carbazole (
1e): mp >300 °C (lit.
[1]
mp >300 °C). IR (KBr): 3404.88, 3078.94, 1570.63, 1492.32, 875.91, 811.22 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ = 11.25 (s, 2 H, NH), 8.24 (d, J = 1.6 Hz, 2 H, H-4, H-7), 7.95 (s, 2 H, H-5, H-6), 7.70 (d, J = 8.4 Hz, 2 H, H-1, H-10), 7.37 (dd, J = 8.4, 2.0 Hz, 2 H, H-2, H-9). MS (EI): m/z = 327 [M + 2], 325 [M+]. Anal. Calcd for C18H10Cl2N2: C, 66.48; H, 3.10; N, 8.61. Found: C, 66.35; H, 3.07; N, 8.42.
17
Hughes DL.
Org. Prep. Proced. Int.
1993,
25:
607
18
General Procedure for Indolo[2,3-
a
]carbazoles (1a-i, 1m-p):
The 2-amino-cyclohexanone hydrochloride 2 (0.334 mmol) and substituted arylhydrazine hydrochloride 3 (4 equiv) were dissolved in 1.5 mL 95% HOAc and 0.5 mL TFA. The mixture was heated to 100 °C until TLC analysis showed complete consumption of the intermediate 1-oxo-1,2,3,4-tetrahydrocarbazoles 4. The mixture was cooled to r.t., H2O was added and the solid was collected by filtration. The crude products were purified by chromatography on silica gel using petroleum ether-EtOAc (5:1) as eluant. The yields in Table
[2]
represent the average of two or more runs.
19 All new compounds gave satisfactory analytical and spectral data. Data for selected compounds are as follows:
Compound 1o (Table
[2]
, entry 15): mp >300 °C. IR (KBr): 3357.15, 3300.33, 3054.31, 1695.67, 1599.14, 1488.63, 740.66 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ = 11.24 (s, 1 H, NH), 11.04 (s, 1 H, NH), 8.14 (d, J = 7.6 Hz, 1 H, Ar-H), 7.73 (s, 1 H, Ar-H), 7.66 (t, J = 7.6 Hz, 2 H, Ar-H), 7.62 (d, J = 7.6 Hz, 2 H, Ar-H), 7.54 (t, J = 7.6 Hz, 2 H, Ar-H), 7.47 (t, J = 7.2 Hz, 1 H, Ar-H), 7.37 (t, J = 7.6 Hz, 1 H, Ar-H), 7.28-7.32 (m, 2 H, Ar-H), 7.16 (t, J = 7.6 Hz, 1 H, Ar-H), 6.90 (t, J = 7.6 Hz, 1 H, Ar-H). MS (EI): m/z = 332 [M+]. Anal. Calcd for C24H16N2: C, 86.72; H, 4.85; N, 8.43. Found: C, 86.61; H, 4.78; N, 8.35.
Compound 1p (Table
[2]
, entry 16): mp >300 °C. IR (KBr): 3419.72, 3355.40, 1703.65, 1567.85, 1455.51, 806.60, 704.63 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ = 11.53 (s, 1 H, NH), 11.32 (s, 1 H, NH), 8.31 (s, 1 H, Ar-H), 7.85 (s, 1 H, Ar-H), 7.74-7.78 (m, 2 H, Ar-H), 7.60-7.66 (m, 4 H, Ar-H), 7.54 (t, J = 6.4 Hz, 7.2 Hz, 1 H, Ar-H), 7.42 (d, J = 8.4 Hz, 1 H, Ar-H), 7.35 (d, J = 8.4 Hz, 1 H, Ar-H), 7.23 (s, 1 H, Ar-H). MS (EI): m/z = 403 [M + 2], 401 [M+]. Anal. Calcd for C24H14Cl2N2: C, 71.83; H, 3.52; N, 6.98. Found: C, 71.69; H, 3.45; N, 6.83.
20
Murakami Y.
Watanabe T.
Yokoyama Y.
Naomachi J.
Iwase H.
Watanabe N.
Morihata M.
Okuyama N.
Kamakura H.
Takahashi T.
Atoda H.
Tojo T.
Morita K.
Ishii H.
Chem. Pharm. Bull.
1993,
41:
1910
21
General Procedure for the Synthesis of Compounds (1j-l):
The 2-amino-cyclohexanone hydrochloride 2a (50 mg, 0.334 mmol) was added to a solution of ortho-halophenyl-hydrazines hydrochloride 3j-l (4 equiv) in n-propyl alcohol (2 mL) at r.t., then the reaction mixture was refluxed for 3 h. The solvent was removed in vacuo, glacial HOAc (3 mL) was added to the residue, and the mixture was refluxed for 12 h. The mixture was cooled to r.t., H2O was added and the solid was collected by filtration. The crude products were purified by chromatography on silica gel using petroleum ether-EtOAc (15:1) as eluant. The results are depicted in Table
[2]
(entries 10-12).
22
Gazengel JM.
Lancelot JC.
Rault S.
Robba M.
J. Heterocycl. Chem.
1990,
27:
1947